PT3043785T - Aplicação de r-cetamina e seu sal como medicamentos - Google Patents

Aplicação de r-cetamina e seu sal como medicamentos

Info

Publication number
PT3043785T
PT3043785T PT147933196T PT14793319T PT3043785T PT 3043785 T PT3043785 T PT 3043785T PT 147933196 T PT147933196 T PT 147933196T PT 14793319 T PT14793319 T PT 14793319T PT 3043785 T PT3043785 T PT 3043785T
Authority
PT
Portugal
Prior art keywords
ketamine
pharmaceuticals
salt
application
Prior art date
Application number
PT147933196T
Other languages
English (en)
Original Assignee
Univ Chiba Nat Univ Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Chiba Nat Univ Corp filed Critical Univ Chiba Nat Univ Corp
Publication of PT3043785T publication Critical patent/PT3043785T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PT147933196T 2013-09-13 2014-09-12 Aplicação de r-cetamina e seu sal como medicamentos PT3043785T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013190066 2013-09-13

Publications (1)

Publication Number Publication Date
PT3043785T true PT3043785T (pt) 2021-11-05

Family

ID=51846870

Family Applications (1)

Application Number Title Priority Date Filing Date
PT147933196T PT3043785T (pt) 2013-09-13 2014-09-12 Aplicação de r-cetamina e seu sal como medicamentos

Country Status (15)

Country Link
US (4) US9872841B2 (pt)
EP (2) EP3964203A1 (pt)
JP (6) JP6366439B2 (pt)
CA (2) CA3143962A1 (pt)
CY (1) CY1125290T1 (pt)
DK (1) DK3043785T3 (pt)
ES (1) ES2897453T3 (pt)
HR (1) HRP20211629T1 (pt)
HU (1) HUE056378T2 (pt)
LT (1) LT3043785T (pt)
PL (1) PL3043785T3 (pt)
PT (1) PT3043785T (pt)
RS (1) RS62516B1 (pt)
SI (1) SI3043785T1 (pt)
WO (1) WO2015037248A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111643449A (zh) 2013-03-15 2020-09-11 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
WO2015037248A1 (en) * 2013-09-13 2015-03-19 National University Corporation Chiba University Application of r-ketamine and salt thereof as pharmaceuticals
EP3193853A1 (en) 2014-09-15 2017-07-26 Janssen Pharmaceutica NV VAL66MET (SNP rs6265) GENOTYPE SPECIFIC DOSING REGIMENS AND METHODS FOR THE TREATMENT OF DEPRESSION
US20160332962A1 (en) * 2015-05-13 2016-11-17 Janssen Pharmaceutica Nv (s)-csa salt of s-ketamine, (r)-csa salt of s-ketamine and processes for the preparation of s-ketamine
EP3297620A4 (en) 2015-06-27 2019-01-09 Shenox Pharmaceuticals, LLC TRANSDERMAL DELIVERY SYSTEM FOR KETAMINE
WO2017087691A1 (en) * 2015-11-17 2017-05-26 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
US20190240184A1 (en) 2016-10-27 2019-08-08 National University Corporation Chiba University Pharmaceutical applications for (s)-norketamine and salts thereof
JP2021003001A (ja) * 2017-09-07 2021-01-14 国立大学法人千葉大学 うつ症状の検査方法、及び治療薬のスクリーニング方法
US20200009081A1 (en) 2017-09-13 2020-01-09 Janssen Pharmaceutica N.V. Delivery Of Esketamine For The Treatment Of Depression
TW201919595A (zh) * 2017-09-27 2019-06-01 國立大學法人千葉大學 作為神經變性疾病或認知機能障礙之預防或治療劑之r-氯胺酮及其衍生物
US11622948B2 (en) 2017-11-09 2023-04-11 The Trustees Of Columbia University In The City Of New York Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders
BR112020012473A2 (pt) 2017-12-22 2020-11-24 Janssen Pharmaceuticals, Inc. escetamina para o tratamento da depressão
JPWO2019160057A1 (ja) * 2018-02-15 2021-02-04 国立大学法人千葉大学 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
AU2019262197A1 (en) * 2018-05-04 2020-11-26 Perception Neuroscience, Inc. Methods of treating substance abuse
US11154537B2 (en) 2018-08-10 2021-10-26 Eleusis Therapeutics Us, Inc. Method of treatment for ketamine infusion
WO2020138491A1 (ja) * 2018-12-27 2020-07-02 国立大学法人千葉大学 神経発達障害の予防または治療剤としてのｒ－ケタミンおよびその誘導体
JP2022524008A (ja) 2019-03-05 2022-04-27 ヤンセン ファーマシューティカルズ，インコーポレーテッド うつ病の治療のためのエスケタミン
CN112125816A (zh) * 2020-03-17 2020-12-25 国药集团工业有限公司 一种氯胺酮、其衍生物或其盐的消旋化方法
AU2021242363A1 (en) * 2020-03-27 2022-11-03 Homeostasis Therapeutics, Limited Method of treatment for anorexia nervosa, bulimia and related clinical syndromes
CN114306219B (zh) * 2020-09-30 2023-09-26 四川普锐特药业有限公司 稳定的r-氯胺酮药物组合物
WO2022118783A1 (ja) * 2020-12-04 2022-06-09 国立大学法人大阪大学 治療抵抗性うつ病または緊急性を有するうつ病の症状を治療するための組成物
CA3234818A1 (en) 2021-10-12 2023-04-20 Perception Neuroscience, Inc. R-ketamine salts and methods of use thereof
WO2023178039A1 (en) 2022-03-14 2023-09-21 Perception Neuroscience, Inc. Pharmaceutical formulations of r-ketamine
CN115006375A (zh) * 2022-06-24 2022-09-06 华中科技大学 艾司氯胺酮用于制备治疗社交障碍药物的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3254124A (en) 1962-06-29 1966-05-31 Parke Davis & Co Aminoketones and methods for their production
CH535201A (de) 1969-12-19 1973-03-31 Bristol Myers Co Verfahren zur Spaltung von racemischen 2-(o-Chlorphenyl)-2-methylaminocyclohexanon in die optisch-aktiven Isomeren
US4670459A (en) 1984-10-03 1987-06-02 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
US5543434A (en) 1994-02-25 1996-08-06 Weg; Stuart L. Nasal administration of ketamine to manage pain
US5679714A (en) 1995-06-07 1997-10-21 Weg; Stuart L. Administration of ketamine for detoxification and treatment of tobacco addiction
DE19619665C2 (de) 1996-05-15 2001-03-08 Goedecke Ag Racemattrennung von Ketamin
US7001609B1 (en) 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
US6382204B1 (en) 1999-10-14 2002-05-07 Becton Dickinson And Company Drug delivery system including holder and drug container
US6962151B1 (en) 1999-11-05 2005-11-08 Pari GmbH Spezialisten für effektive Inhalation Inhalation nebulizer
DK2105449T3 (da) 2000-02-23 2019-10-07 Amgen Inc Antagonistiske selektive bindemidler af osteoprotegerinbindende protein
BRPI0002693B8 (pt) 2000-06-19 2021-05-25 Cristalia Produtos Quim Farmaceuticos Ltda processo de obtenção dos enantiômeros da cetamina e seus sais farmaceuticamente aceitáveis
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
EP1551393A4 (en) 2002-07-30 2010-06-16 Peter Migaly COMBINATION OF THERAPY FOR DEPRESSION, PREVENTION OF SUICIDE AND VARIOUS MEDICAL AND PSYCHIATRIC DISORDERS
US7273889B2 (en) 2002-09-25 2007-09-25 Innovative Drug Delivery Systems, Inc. NMDA receptor antagonist formulation with reduced neurotoxicity
DE60327883D1 (de) 2002-11-18 2009-07-16 Yaupon Therapeutics Inc Analgetische verwendung von (s)-norketamin
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
EA017264B1 (ru) 2005-09-28 2012-11-30 Аурис Медикаль Аг Применение композиции арилциклоалкиламида для получения лекарственного препарата для лечения нарушения внутреннего уха
US8785500B2 (en) 2006-03-22 2014-07-22 Icahn School Of Medicine At Mount Sinai Intranasal administration of ketamine to treat depression
US20120225949A1 (en) * 2009-08-14 2012-09-06 Demitri Papalos Compositions and methods for treating bipolar disorder
US20110038807A1 (en) * 2009-08-14 2011-02-17 Demitri Papolos Compositions and methods for treating bipolar disorder
KR20140136982A (ko) 2012-03-12 2014-12-01 얀센 파마슈티카 엔.브이. 치료-불응성 또는 치료-저항성 우울증 치료용 에스케타민
JP6722453B2 (ja) 2012-08-23 2020-07-15 スチュアート エル ウェグ 抗不安薬組成物、製剤および使用方法
ES2745024T3 (es) 2013-03-15 2020-02-27 Janssen Pharmaceutica Nv Composición farmacéutica de clorhidrato de S-ketamina
CN111643449A (zh) 2013-03-15 2020-09-11 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
JP6462663B2 (ja) 2013-04-12 2019-01-30 アイカーン スクール オブ メディシン アット マウント シナイ 心的外傷後ストレス障害を処置するための方法
WO2015037248A1 (en) 2013-09-13 2015-03-19 National University Corporation Chiba University Application of r-ketamine and salt thereof as pharmaceuticals
CA2936809A1 (en) 2014-01-14 2015-07-23 Children's Hospital Medical Center Compositions comprising ketamine for treating an autism spectrum disorder
WO2016025581A1 (en) 2014-08-13 2016-02-18 Janssen Pharmaceutica Nv Method for the treatment of depression
EP3085366A1 (en) 2015-04-22 2016-10-26 Institut du Cerveau et de la Moelle Epiniere-ICM Nmda antagonists for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior
WO2016186968A1 (en) 2015-05-15 2016-11-24 The Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating motor disorders
WO2017087691A1 (en) 2015-11-17 2017-05-26 The Trustees Of Columbia University In The City Of New York Pharmacological prophylactics against stress-induced affective disorders and their associated symptoms
TW201919595A (zh) 2017-09-27 2019-06-01 國立大學法人千葉大學 作為神經變性疾病或認知機能障礙之預防或治療劑之r-氯胺酮及其衍生物
JPWO2019160057A1 (ja) 2018-02-15 2021-02-04 国立大学法人千葉大学 炎症性疾患若しくは骨疾患の予防又は治療剤及び医薬組成物
AU2019262197A1 (en) 2018-05-04 2020-11-26 Perception Neuroscience, Inc. Methods of treating substance abuse
WO2020138491A1 (ja) 2018-12-27 2020-07-02 国立大学法人千葉大学 神経発達障害の予防または治療剤としてのｒ－ケタミンおよびその誘導体
US10973780B2 (en) 2019-05-15 2021-04-13 Bexson Biomedical, Inc. Ketamine formulation for subcutaneous injection

Also Published As

Publication number Publication date
HUE056378T2 (hu) 2022-02-28
US20190343781A1 (en) 2019-11-14
WO2015037248A1 (en) 2015-03-19
US9872841B2 (en) 2018-01-23
ES2897453T3 (es) 2022-03-01
US20160220513A1 (en) 2016-08-04
US20220071929A1 (en) 2022-03-10
JP6842206B2 (ja) 2021-03-17
JP2024009274A (ja) 2024-01-19
US11207279B2 (en) 2021-12-28
SI3043785T1 (sl) 2022-02-28
EP3043785A1 (en) 2016-07-20
JP7398836B2 (ja) 2023-12-15
CY1125290T1 (el) 2023-03-24
US10406121B2 (en) 2019-09-10
CA3143962A1 (en) 2015-03-19
EP3964203A1 (en) 2022-03-09
CA2923685A1 (en) 2015-03-19
CA2923685C (en) 2022-03-08
US20180177745A1 (en) 2018-06-28
JP6615277B2 (ja) 2019-12-04
JP2023011027A (ja) 2023-01-20
JP2020015766A (ja) 2020-01-30
LT3043785T (lt) 2021-12-10
HRP20211629T1 (hr) 2022-02-04
JP2015078181A (ja) 2015-04-23
JP2021073310A (ja) 2021-05-13
RS62516B1 (sr) 2021-11-30
PL3043785T3 (pl) 2022-02-28
JP2018145207A (ja) 2018-09-20
EP3043785B1 (en) 2021-08-25
DK3043785T3 (da) 2021-11-15
JP6366439B2 (ja) 2018-08-01

Similar Documents

Publication Publication Date Title
PL3043785T3 (pl) Zastosowanie R-ketaminy i jej soli jako środków farmaceutycznych
HK1254296A1 (zh) 治療性化合物和其用途
IL243608A0 (en) Substances with antiviral activity, preparations containing them and their uses
HK1217092A1 (zh) 治療性化合物及其用途
HK1214255A1 (zh) -醯基氨基噻唑衍生物或其鹽
SG11201507897SA (en) Salt of pyrazoloquinoline derivative, and crystal thereof
IL243614A0 (en) Consequences of mutated pyrazolylpyrazole and its use as a herbicide
PT2967044T (pt) Composição herbicida e seu método de uso
IL243613B (en) Consequences of mutated pyrazolylpyrazole and its use as a herbicide
IL243615A0 (en) Consequences of mutated pyrazolylpyrazole and its use as a herbicide
HK1219691A1 (zh) 醫藥組成物及其用途
GB201312698D0 (en) Preparation and use of zinc compounds
IL240177A0 (en) Converted chromium-6-yloxy-cycloalkanes and their use as drugs
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
IL240447A0 (en) Propionic-biaryl acid derivatives and their use as pharmaceutical preparations
IL243616A0 (en) Consequences of mutated pyrazolylpyrazole and its use as a herbicide
GB201303476D0 (en) Agrochemical composition and method of use thereof
IL240422A0 (en) Bi-aryl derivatives of propionic acid and their use as medicinal preparations
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
AU2013902711A0 (en) Compounds and methods of their use - IV
GB201310349D0 (en) Composition and method of use thereof
GB201301928D0 (en) Composition and method of use thereof